215 related articles for article (PubMed ID: 30353737)
1. Immunosuppression and HIV Viremia Associated with More Atherogenic Lipid Profile in Older People with HIV.
Levy ME; Greenberg AE; Magnus M; Younes N; Castel A;
AIDS Res Hum Retroviruses; 2019 Jan; 35(1):81-91. PubMed ID: 30353737
[TBL] [Abstract][Full Text] [Related]
2. Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth.
Neilan AM; Karalius B; Patel K; Van Dyke RB; Abzug MJ; Agwu AL; Williams PL; Purswani M; Kacanek D; Oleske JM; Burchett SK; Wiznia A; Chernoff M; Seage GR; Ciaranello AL;
JAMA Pediatr; 2017 May; 171(5):450-460. PubMed ID: 28346597
[TBL] [Abstract][Full Text] [Related]
3. The effects of age on associations between markers of HIV progression and markers of metabolic function including albumin, haemoglobin and lipid concentrations.
Samuel M; Jose S; Winston A; Nelson M; Johnson M; Chadwick D; Fisher M; Leen C; Gompels M; Gilson R; Post FA; Hay P; Sabin CA;
HIV Med; 2014 May; 15(5):311-6. PubMed ID: 24245861
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D study.
Kamara DA; Smith C; Ryom L; Reiss P; Rickenbach M; Phillips A; Mocroft A; De Wit S; Law M; Monforte AD; Dabis F; Pradier C; Lundgren JD; Sabin C
Antivir Ther; 2016; 21(6):495-506. PubMed ID: 27114439
[TBL] [Abstract][Full Text] [Related]
5. Ethnicity and discordance in plasma HIV-1 RNA viral load and CD4+ lymphocyte count in a cohort of HIV-1-infected individuals.
Smith PR; Sarner L; Murphy M; James B; Thomas JM; Skinner CJ; Aitken C
J Clin Virol; 2003 Jan; 26(1):101-7. PubMed ID: 12589840
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of low high-density lipoprotein among young adults receiving antiretroviral therapy in Zambia: An opportunity to consider non-communicable diseases in resource-limited settings.
Hamooya BM; Musonda P; Mutale W; Masenga SK; Halwiindi H; Mutengo KH; Chiyeñu KOR; Chongwe G; Koethe JR; Lipworth L; Heimburger DC
PLoS One; 2021; 16(2):e0247004. PubMed ID: 33592027
[TBL] [Abstract][Full Text] [Related]
7. Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load.
Asgari MM; Ray GT; Quesenberry CP; Katz KA; Silverberg MJ
JAMA Dermatol; 2017 Sep; 153(9):892-896. PubMed ID: 28700773
[TBL] [Abstract][Full Text] [Related]
8. Low HDL-cholesterol among HIV-1 infected and HIV-1 uninfected individuals in Nairobi, Kenya.
Njoroge A; Guthrie BL; Bosire R; Wener M; Kiarie J; Farquhar C
Lipids Health Dis; 2017 Jun; 16(1):110. PubMed ID: 28599673
[TBL] [Abstract][Full Text] [Related]
9. Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients.
Bastard JP; Soulié C; Fellahi S; Haïm-Boukobza S; Simon A; Katlama C; Calvez V; Marcelin AG; Capeau J
Antivir Ther; 2012; 17(5):915-9. PubMed ID: 22436412
[TBL] [Abstract][Full Text] [Related]
10. Association Between CD4
Islam M; Ramesh N; Kolman S; Koshy S; Frank M; Salomon N; Miller A; Harris M
Lung; 2017 Oct; 195(5):635-642. PubMed ID: 28647827
[TBL] [Abstract][Full Text] [Related]
11. Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study.
Hernández-Ramírez RU; Qin L; Lin H; Leyden W; Neugebauer RS; Althoff KN; Achenbach CJ; Hessol NA; D'Souza G; Gebo KA; Gill MJ; Grover S; Horberg MA; Li J; Mathews WC; Mayor AM; Park LS; Rabkin CS; Salters K; Justice AC; Moore RD; Engels EA; Silverberg MJ; Dubrow R;
Lancet HIV; 2019 Apr; 6(4):e240-e249. PubMed ID: 30826282
[TBL] [Abstract][Full Text] [Related]
12. CD4+ cells recovery in HIV positive patients with severe immunosuppression at HAART initiation at Centre Medico-Social Cor-Unum, Kigali.
Merci NM; Emerence U; Augustin N; Habtu M; Julie I; Angelique T; Jessica B; Cynthia A; Penda AT
Pan Afr Med J; 2017; 26():14. PubMed ID: 28450993
[TBL] [Abstract][Full Text] [Related]
13. [Study on the relationship between HIV drug resistance and CD4(+)T cell counts among antiretroviral therapy patients with low viral load].
Liu PT; Xing H; Liao LJ; Leng XB; Wang J; Kan W; Yan J; Zuo ZB; Ruan YH; Shao YM
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):277-281. PubMed ID: 29973007
[No Abstract] [Full Text] [Related]
14. Accuracy of self-report of HIV viral load among people with HIV on antiretroviral treatment.
Sewell J; Daskalopoulou M; Nakagawa F; Lampe FC; Edwards S; Perry N; Wilkins E; O'Connell R; Jones M; Collins S; Speakman A; Phillips AN; Rodger AJ;
HIV Med; 2017 Aug; 18(7):463-473. PubMed ID: 28004523
[TBL] [Abstract][Full Text] [Related]
15. Effect of early syphilis infection on plasma viral load and CD4 cell count in human immunodeficiency virus-infected men: results from the FHDH-ANRS CO4 cohort.
Jarzebowski W; Caumes E; Dupin N; Farhi D; Lascaux AS; Piketty C; de Truchis P; Bouldouyre MA; Derradji O; Pacanowski J; Costagliola D; Grabar S;
Arch Intern Med; 2012 Sep; 172(16):1237-43. PubMed ID: 22826097
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol efflux responds to viral load and CD4 counts in HIV+ patients and is dampened in HIV exposed.
Tort O; Escribà T; Egaña-Gorroño L; de Lazzari E; Cofan M; Fernandez E; Gatell JM; Martinez E; Garcia F; Arnedo M
J Lipid Res; 2018 Nov; 59(11):2108-2115. PubMed ID: 30213800
[TBL] [Abstract][Full Text] [Related]
17. Comparison of once-daily fosamprenavir boosted with either 100 or 200 mg of ritonavir, in combination with abacavir/lamivudine: 96-week results from COL100758.
Hicks CB; DeJesus E; Sloan LM; Sension MG; Wohl DA; Liao Q; Ross LL; Pakes GE; Pappa KA; Lancaster CT;
AIDS Res Hum Retroviruses; 2009 Apr; 25(4):395-403. PubMed ID: 19320570
[TBL] [Abstract][Full Text] [Related]
18. Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients.
Gianotti N; Cozzi-Lepri A; Antinori A; Castagna A; De Luca A; Celesia BM; Galli M; Mussini C; Pinnetti C; Spagnuolo V; d'Arminio Monforte A; Ceccherini-Silberstein F; Andreoni M;
PLoS One; 2017; 12(2):e0171611. PubMed ID: 28192453
[TBL] [Abstract][Full Text] [Related]
19. Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia.
Mocroft A; Phillips AN; Ledergerber B; Katlama C; Chiesi A; Goebel FD; Knysz B; Antunes F; Reiss P; Lundgren JD
AIDS; 2006 May; 20(8):1141-50. PubMed ID: 16691065
[TBL] [Abstract][Full Text] [Related]
20. Low-level HIV viremia is associated with microbial translocation and inflammation.
Reus S; Portilla J; Sánchez-Payá J; Giner L; Francés R; Such J; Boix V; Merino E; Gimeno A
J Acquir Immune Defic Syndr; 2013 Feb; 62(2):129-34. PubMed ID: 23018379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
